This information was published on 2025-12-11T05:13:22 for IP Right Filed Published.
| Field | Value |
| (210) | 2611152 (IR 1891345) |
| (220) |
29 Aug 2025
|
| (300) |
EM, 29 Apr 2025, 019179696
|
| (511) (510) |
Class 42
Research and development services in the field of pharmaceuticals and drug discovery; development of processes and methods for medical and veterinary purposes; development of preparations for medical and veterinary purposes; scientific research for medical purposes, namely, screening for the identification of drug candidates; development of precision RNA therapeutics; development of tailored RNA-based corrective interventions to target the root causes of serious diseases; research and development of new medical products for others; development and identification of novel druggable sites for pharmacological intervention using a bioinformatic discovery platform in a wet lab; screening services, bioinformatics services and modelling services to harness natural processes and modulate gene expression through platforms to generate optimized small molecules, antisense oligonucleotides (ASOs) and small interfering RNAs (siRNAs); designing and implementing multiplexed high-throughput assays to screen for small molecules that modulate RNA processing using bioinformatic tools. |
| (540) | SpliceMatrix |
| (550) | Word |
| (730) |
Contera Pharma A/S
|
Find out more about publications on the About page.